Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Each medication has a different titration schedule and expected weight loss profile based on clinical trial data
Out-of-pocket costs put treatment out of reach for most
The drugs mimic GLP-1, a hormone the body produces after eating, which can decrease appetite and help the body manage insulin production
Are hormone and metabolic health managed together in your benefits package or split across separate vendors
An advance copy of the Federal Register notice is available at the following link: To view or add a comment, sign in Early stable or rising PSA does not preclude subsequent biochemical or pain response with additional cycles of Lu-PSMA-617 treatment
No appeal will succeed Prior authorization attempt wastes 4 to 6 weeks You'll end up paying out-of-pocket anyway Compounded cost ($250-400/month) is lower than brand-name retail ($1,200-1,400/month) Scenario 2: You don't have diabetes and your BMI is 27-29 with no documented comorbidities
US$ 25.28
US$ 29.76
US$ 29.22
US$ 24.16
